Amniotic Membrane Market is projected to reach US$ 5.30 Billion by 2030, propelled by rising surgical procedures, technological advances, and growing awareness of its exceptional healing properties in diverse medical applications
13 Oct, 2023

In a report titled "Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030," published recently by Renub Research, market share insights are included along with a thorough industry analysis. The report also includes research on regions, competitors, and the recent expansion of the Amniotic Membrane Market.

Amniotic Membrane Market is projected to grow at a CAGR of 11.68% between 2022 and 2030. The amniotic membrane market is experiencing a notable upswing fuelled by a heightened awareness of its exceptional healing properties across diverse medical applications. Both healthcare professionals and patients are increasingly recognizing the benefits of amniotic membranes in treating conditions such as surgical wounds, burns, chronic wounds, dry eye disease, corneal ulcers, osteoarthritis, tendonitis, skin conditions, and dental issues.

Renowned for its anti-inflammatory, anti-scarring, and antimicrobial attributes, amniotic membrane creates a crucial moist wound environment essential for effective healing. This growing awareness is translating into an escalating demand for amniotic membrane products and treatments, thereby propelling the overall growth of the amniotic membrane market.

Report Details:

Furthermore, the worldwide surge in surgical procedures, estimated at 234 million by the International Hospital Federation, is significantly influencing the amniotic membrane market. Amniotic membrane, known for its versatility and effectiveness, is becoming a key player in treating various surgical wounds. Its applications span orthopedic, cardiovascular, neurological, gastrointestinal, and plastic surgery wounds, offering advantages over traditional dressings and synthetic materials. As surgical procedures continue to rise globally, the demand for amniotic membranes in wound care is experiencing a corresponding positive impact.

Also, technological advancements are significantly improving the amniotic membrane market by enhancing the effectiveness, durability, and affordability of amniotic membrane products. These innovations, encompassing improved processing techniques and streamlined delivery systems like innovative patches, result in extended shelf lives and heightened healing properties. Beyond traditional applications, these advancements are opening doors to novel uses in regenerative medicine, with amniotic membranes being employed in treating conditions such as spinal cord injuries and osteoarthritis. Pioneering companies are driving this evolution, developing amniotic membrane-based scaffolds for repairing spinal cord injuries, underscoring the ongoing transformation, and broadening applications of amniotic membranes in medical innovation.

Cryopreserved Amniotic Membrane stands at the forefront of the amniotic membrane market

Cryopreserved Amniotic Membrane (AM) boasts unparalleled biological and structural integrity, preserved at ultra-low temperatures (-80°C), surpassing dehydrated and fresh AM in efficacy and durability. Its popularity in ophthalmology, wound care, and orthopedic surgery is driven by proven effectiveness in treating corneal ulcers, dry eye disease, and chronic wounds. Increasing global accessibility, supported by affordability and growing evidence, positions cryopreserved AM as a versatile solution. Notable applications include:

• Ophthalmic treatments for corneal conditions.
• Wound care for burns and chronic wounds.
• Orthopedic use in post-surgical healing and conditions like osteoarthritis and tendonitis.

Surgical wounds are gaining popularity in the amniotic membrane market due to their remarkable therapeutic benefits

Surgical wounds fuel the expanding amniotic membrane market, driven by a rising global prevalence of surgical procedures due to an aging population, increased chronic diseases, and technological advancements. This heightened demand for wound care sees amniotic membrane shine with its anti-inflammatory, anti-scarring, and antimicrobial attributes. Versatile across orthopedic, cardiovascular, neurological, gastrointestinal, and plastic surgeries, it stands out. Supported by robust evidence, such as Wound Repair and Regeneration studies, showcasing its superiority over traditional dressings, amniotic membrane emerges as a critical solution for optimizing healing outcomes in diverse surgical scenarios.

Ambulatory Surgical Centers (ASCs) are poised for future growth in the amniotic membrane market

Ambulatory surgical centers (ASCs) are poised for significant growth in the market, driven by rising demand for outpatient surgery fuelled by an aging population, increased chronic diseases, and technological advancements, leading to a notable increase in ASC numbers. Amniotic membrane, known for its potent healing attributes and capacity to establish a crucial moist wound environment, is widely embraced. Its versatility spans applications in orthopedic, cardiovascular, neurological, gastrointestinal, and plastic surgeries. The cost-effectiveness of ASCs in outpatient surgeries enhances their appeal to patients and insurers, further emphasizing the amniotic membrane's efficacy in promoting healing and minimizing complications in diverse surgical scenarios.

United States commands a prominent position in the amniotic membrane market

The United States' leadership in the amniotic membrane market arises from a surge in surgical procedures driven by an aging population, increased chronic diseases, and technological advancements. The well-established healthcare system ensures accessible amniotic membrane products, fostering widespread adoption. Research and development leadership and government support accelerate innovation and market growth. Rising awareness, broader availability, and supportive reimbursement programs strengthen the nation's dominance. Leading manufacturers and esteemed research institutions, including Amniox Medical, MiMedx, Mayo Clinic, and Cleveland Clinic, underscore the United States' pivotal role in advancing amniotic membrane applications.

Competitive Landscape

The major players in the amniotic membrane market include Stryker Corporation, Smith & Nephew, Integra LifeSciences Holdings, MiMedx, Organogenesis Net, Wright Medical Group, Applied Biologics LLC, FzioMedInc, Katena, Inc., and Tissue-Tech Inc.

Market Summary

• Product - The report analyses the Amniotic Membrane Market by-product from two angles (Cryopreserved Amniotic Membranes and Lyophilization Amniotic Membrane).
• Application - A Renub Research report on the Amniotic Membrane Market looks at the application from three angles (Surgical Wounds, Ophthalmology, and Others).
• End-User - The report analyses the Amniotic Membrane Market by end-user from four angles (Hospital, Ambulatory Surgical Centers, Specialty Clinics, and Research and academic Institutes).
• Countries - There are twenty-four different perspectives on the Amniotic Membrane Market by countries (United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, South Africa, Israel, Australia, UAE, and Rest of World).
• Key Players - Every significant player in the Amniotic Membrane Market has been discussed from three perspectives (Overview, Recent Developments, and Revenue): Stryker Corporation, Smith & Nephew, Integra LifeSciences Holdings, MiMedx, Organogenesis Net, Wright Medical Group, Applied Biologics LLC, FzioMedInc, Katena, Inc., and Tissue-Tech Inc.

About Us

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-478-202-3244 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research